Pregnancy-induced cytotoxicity of splenocytes against mammary tumor cells in rats
- PMID: 1745492
- DOI: 10.1159/000226973
Pregnancy-induced cytotoxicity of splenocytes against mammary tumor cells in rats
Abstract
Our earlier observations indicate the possibility of involvement of a 'host factor' in pregnancy-induced protection against mammary carcinogenesis. The present investigation is an attempt to determine if this "host factor" is of immunological nature. Rat mammary tumors induced by 7,12-dimethylbenz[a]anthracene were used as target, and splenocytes from parous rats of the same strain were used as effector cells. The parous rats were divided into two groups according to the time period after parturition. Group 1 contained rats which were 5-13 days after delivery, group 2 had rats 14 or more days after parturition. In vitro cytotoxicity was determined by incubating the tumor cells with spleen cells in the target:effector ratios of 1:3, 1:10 and 1:30. Both groups 1 and 2 showed significant lysis of mammary tumor cells. These results were confirmed by the trypan blue exclusion test. The results showed a significantly higher cytotoxic capability of the spleen cells from parous rats against mammary tumor cells as compared to spleen cells from age-matched nulliparous rats.
Similar articles
-
Inhibition of mammary tumorigenesis in virgin rats by adoptive transfer of splenocytes from parous donors.Cancer Immunol Immunother. 1991;33(4):263-6. doi: 10.1007/BF01744946. Cancer Immunol Immunother. 1991. PMID: 2059970 Free PMC article.
-
Pregnancy-induced antitumor cytotoxicity of T cell-rich fraction against mammary adenocarcinoma cells in rats.Carcinogenesis. 1992 Dec;13(12):2449-52. doi: 10.1093/carcin/13.12.2449. Carcinogenesis. 1992. PMID: 1473255
-
Pregnancy induced mammary tumor specific effector cells are present long after parturition in a breast cancer model in rats.Cancer Lett. 2000 Jun 1;154(1):1-7. doi: 10.1016/s0304-3835(99)00435-8. Cancer Lett. 2000. PMID: 10799733
-
Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy.Br J Cancer. 1988 Apr;57(4):390-4. doi: 10.1038/bjc.1988.88. Br J Cancer. 1988. PMID: 3134040 Free PMC article.
-
Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway.Breast Cancer Res. 2004;6(4):R423-36. doi: 10.1186/bcr812. Epub 2004 Jun 4. Breast Cancer Res. 2004. PMID: 15217511 Free PMC article.
Cited by
-
Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis.Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11755-9. doi: 10.1073/pnas.201393798. Proc Natl Acad Sci U S A. 2001. PMID: 11573010 Free PMC article.
-
Parity improves anti-tumor immunity in breast cancer patients.Oncotarget. 2017 Sep 8;8(62):104981-104991. doi: 10.18632/oncotarget.20756. eCollection 2017 Dec 1. Oncotarget. 2017. PMID: 29285226 Free PMC article.
-
Inhibition of mammary tumorigenesis in virgin rats by adoptive transfer of splenocytes from parous donors.Cancer Immunol Immunother. 1991;33(4):263-6. doi: 10.1007/BF01744946. Cancer Immunol Immunother. 1991. PMID: 2059970 Free PMC article.
-
Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.Neurosurg Rev. 2019 Jun;42(2):351-369. doi: 10.1007/s10143-018-0953-1. Epub 2018 Feb 17. Neurosurg Rev. 2019. PMID: 29453736 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources